+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Clinical Proteomics"

Protein Expression Market - A Global and Regional Analysis: Focus on Application, End User, Product, Expression System, and Region - Analysis and Forecast, 2023-2033 - Product Thumbnail Image

Protein Expression Market - A Global and Regional Analysis: Focus on Application, End User, Product, Expression System, and Region - Analysis and Forecast, 2023-2033

  • Report
  • February 2024
  • 169 Pages
  • Global
From
Proteomics: Technologies and Global Markets - Product Thumbnail Image

Proteomics: Technologies and Global Markets

  • Report
  • December 2022
  • 384 Pages
  • Global
From
Proteomics - Technologies, Markets and Companies - Product Thumbnail Image

Proteomics - Technologies, Markets and Companies

  • Report
  • November 2021
  • 656 Pages
  • Global
From
Clinical Proteomics. From Diagnosis to Therapy. Edition No. 1 - Product Thumbnail Image

Clinical Proteomics. From Diagnosis to Therapy. Edition No. 1

  • Book
  • November 2007
  • 694 Pages
  • 4 Results (Page 1 of 1)
Loading Indicator

Clinical Proteomics is a field of proteomics that focuses on the application of proteomics technologies to the study of human health and disease. It involves the identification and quantification of proteins in biological samples, such as blood, tissue, and urine, to gain insights into the molecular basis of disease. Clinical Proteomics is used to identify biomarkers for diagnosis, prognosis, and treatment of diseases, as well as to develop new therapeutic strategies. It is also used to monitor the effectiveness of treatments and to identify potential drug targets. Companies in the Clinical Proteomics market include Thermo Fisher Scientific, Agilent Technologies, Bio-Rad Laboratories, Bruker Corporation, and Waters Corporation. Show Less Read more